Delivery Order SPE2DB22D2007-SPE2DB24FJ4YW

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.30 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,550.83 Firm Fixed Price Delivery Order contract is for the supply of 4566615955 ! ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.87 Firm Fixed Price Delivery Order contract covers the provision of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML" with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $1,143.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4566778161 ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of December 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,731.23 firm fixed-price delivery order contract is for ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,566,120,746 ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. The $2,211.30 firm fixed price contract has an ultimate completion date of October 17, 2024. This contract is not a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $13,865.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a $999,999,999 IDC that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award covers the...
This federal contract award, valued at $13,726.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of medical products, including a specific pharmaceutical product, ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,690.97, is a Firm Fixed Price Delivery Order for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of February 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,790.68, is a Firm Fixed Price Delivery Order for "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical supplies. The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4YW
    Delivery Order

This federal contract award, valued at $12,458.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment programs and facilities worldwide. The award has an ultimate completion date of August 9, 2024.

Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, and the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024. These IDCs enable government agencies to efficiently procure essential pharmaceutical and medical supplies from Amerisourcebergen, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside designation.

Generated 11/7/24, 9:03 AM